Close
Smartlab Europe
Achema middle east

IT & Data Management

AI in Pharma Market Access and Commercialization: Transforming Pricing and Tender Strategies

The pharmaceutical industry is undergoing a profound transformation in how it approaches pricing decisions, market access negotiations, and tender participation through the strategic deployment of artificial intelligence technologies. AI in pharma market access represents a paradigm shift from traditional...

IoT and Edge Computing for Real-Time Pharmaceutical Manufacturing Insights

The pharmaceutical manufacturing sector stands on the precipice of a fundamental digital transformation driven by the convergence of Internet of Things technologies, edge computing, artificial intelligence, and advanced analytics platforms. IoT in pharma manufacturing represents far more than simple...

CRISPR and Gene Editing: Next-Gen Manufacturing Impacts

The pharmaceutical and biotechnology industries are experiencing a profound technological revolution driven by CRISPR-Cas9 and emerging gene editing technologies that fundamentally alter how therapeutic agents are developed and manufactured. Gene editing pharma manufacturing represents far more than incremental improvement...

In Silico and Virtual Trials: Revolutionizing Drug Development

Drug development is entering an era of radical transformation as pharmaceutical companies embrace virtual trials and in silico methodologies to reimagine the clinical research process. These digital-first strategies tap into computational models, artificial intelligence, and patient-specific simulations to address...

AI-Enabled Supply Chain Resilience in Pharmaceutical Manufacturing

Pharmaceutical supply chains are fundamentally evolving as global disruptions, regulatory demands, and patient expectations converge to redefine how drugs reach the market. In today’s environment, pharmaceutical supply chain resilience depends not only on physical infrastructure and traditional logistics but...

Nabla & Takeda Expand Partnership on AI In Drug Development

Nabla Bio, the U.S. biotech firm, said on October 14, 2025, that it has signed a second major research partnership along with Takeda Pharmaceutical, the Japanese drugmaker, thereby deepening their usage of AI in drug development. As per the new...

Novel Excipients for Next Generation Drug Formulation

Exploring Novel Excipients for Next Generation Drug Formulation The landscape of pharmaceutical development finds itself at a critical juncture where the complexity of drug molecules increasingly outpaces the capabilities of traditional formulation approaches. Novel excipients drug formulation represents not merely...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »